David D. Meek, Chief Executive Officer at Mirati Therapeutics, Inc. (MRTX), sold 6,358 shares at $42.38 ($269K) on 2023-01-17, disclosed to the SEC on 2023-01-19.
Open-market sale of $269k MRTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.38 | 3,179 | $135K | 50.0% |
| 2 | $42.38 | 3,179 | $135K | 50.0% |
| Total | $42.38 avg | 6,358 | $269K | 100% |
| Filing → |
| QURE | SELL | 2024-06-17 | $11K | — | Filing → |
| QURE | SELL | 2023-06-20 | $43K | — | Filing → |
| QURE | SELL | 2023-03-01 | $8K | — | Filing → |